Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Allergy & Immunology
•
Allergic Skin Diseases
•
Drug Allergy
Do you utilize any desensitization protocols for delayed hypersensitivity reactions?
Related Questions
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
Are drug challenges after serum sickness-like reactions useful in delabeling the allergy?
Do you perform patch testing with a history of SCAR with the goal of performing a drug challenge?
Do you recommend desensitization to biologics since this has to occur repeatedly?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
Are you using any AI models to de-label penicillin allergy?
How do you manage atopic dermatitis in pediatric patients who has failed dupilumab?
Do you utilize AIT for atopic dermatitis if there is no AR present?
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
